US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

4D Molecular Therapeutics

9.25

+0.15001.65%

Post-market: 9.250.00000.00%17:47 EST

Volume:534.89K

Turnover:4.85M

Market Cap:471.82M

PE:-2.47

High:9.29

Open:9.10

Low:8.75

Close:9.10

52wk High:12.34

52wk Low:2.24

Shares:51.01M

Float Shares:36.78M

Volume Ratio:0.65

T/O Rate:1.45%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.7446

EPS(LYR):-2.9821

ROE:-45.38%

ROA:-27.64%

PB:1.28

PE(LYR):-3.10

Loading ...

Overview Company News Filings

4D Molecular Therapeutics Completes Enrollment for Phase 3 Wet AMD Trial of 4D-150

4Dmt Completes Enrollment for 4Front-1 Phase 3 Clinical Trial of 4D-150 in Wet Amd

THOMSON REUTERS

4D Molecular Therapeutics Initiated at Overweight by Barclays

4D Molecular Therapeutics Issues Pre-Funded Warrants in Exchange for Common Stock

4D Molecular announces employment inducement grants

Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Centene (CNC) and Cencora (COR)

4D Molecular Therapeutics Unveils Gene Therapy Pipeline Targeting Retinal Diseases

BRIEF-4Dmt Provides Company Update And Anticipated Development Milestones For 2026

4D Molecular Therapeutics Reports Strong Cash Position and Advances Key Clinical Programs

Glenn Sblendorio Joins 4D Molecular Therapeutics Board of Directors

4Dmt Provides Company Update and Anticipated Development Milestones for 2026

THOMSON REUTERS

4D Molecular Therapeutics Inc. Files Initial Beneficial Ownership Statement for Officer Christopher Paul Simms

Chief Legal Officer Scott Bizily Reports Disposal of 4D Molecular Therapeutics Inc. Common Shares

4D Molecular Therapeutics Is Maintained at Buy by Chardan Capital

4D Molecular Therapeutics Reports Positive Interim Phase 1 Results for 4D-710 in Cystic Fibrosis

4Dmt Announces Positive Interim Clinical Data From 4D-710 Aerow Phase 1 Clinical Trial in Cystic Fibrosis Lung Disease

THOMSON REUTERS

4D Molecular Therapeutics Grants 13,800 RSUs to New Employees Under Inducement Plan

4D Molecular Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Kristian Humer, Chief Financial Officer

4D Molecular Therapeutics to Present at J.P. Morgan Healthcare Conference

Chief Legal Officer Scott Bizily Reports Disposal of 4D Molecular Therapeutics Inc. Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/FDMT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FDMT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FDMT\",,,,,undefined,":{"symbol":"FDMT","market":"US","secType":"STK","nameCN":"4D Molecular Therapeutics","latestPrice":9.25,"timestamp":1770843600000,"preClose":9.1,"halted":0,"volume":534888,"hourTrading":{"tag":"盘后","latestPrice":9.25,"preClose":9.25,"latestTime":"17:47 EST","volume":3668,"amount":33929.5899,"timestamp":1770850053438,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.016483516483516522,"floatShares":36783600,"shares":51007900,"eps":-3.744606,"marketStatus":"Not Yet Opened","change":0.15,"latestTime":"02-11 16:00:00 EST","open":9.1,"high":9.285,"low":8.75,"amount":4852575.610992,"amplitude":0.058791,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.744606,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770886800000},"marketStatusCode":0,"adr":0,"listingDate":1607662800000,"exchange":"NASDAQ","adjPreClose":9.1,"preHourTrading":{"tag":"盘前","latestPrice":9.12,"preClose":9.1,"latestTime":"09:29 EST","volume":594,"amount":5417.239608,"timestamp":1770820199999,"change":0.02,"changeRate":0.002198,"amplitude":0.004396},"postHourTrading":{"tag":"盘后","latestPrice":9.25,"preClose":9.25,"latestTime":"17:47 EST","volume":3668,"amount":33929.5899,"timestamp":1770850053438,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.64931,"impliedVol":0.4484,"impliedVolPercentile":0.1235},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FDMT\",,,,,undefined,":{"symbol":"FDMT","floatShares":36783600,"roa":"-27.64%","roe":"-45.38%","lyrEps":-2.982143,"volumeRatio":0.64931,"shares":51007900,"dividePrice":0,"high":9.285,"amplitude":0.058791,"preClose":9.1,"low":8.75,"week52Low":2.235,"pbRate":"1.28","psRate":"3931.86","week52High":12.34,"institutionHeld":0,"latestPrice":9.25,"eps":-3.744606,"divideRate":0,"volume":534888,"delay":0,"ttmEps":-3.744606,"open":9.1,"prevYearClose":7.5,"prevWeekClose":8.99,"prevMonthClose":8.86,"prevQuarterClose":7.5,"fiveDayClose":9.29,"twentyDayClose":7.86,"sixtyDayClose":10.28},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FDMT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-10","symbol":"FDMT","fiscalQuarterEnding":"2025/09","expectedEps":-1.02,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-1.01},{"market":"US","date":"2025-08-11","symbol":"FDMT","fiscalQuarterEnding":"2025/06","expectedEps":-0.88,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-0.98},{"market":"US","date":"2025-05-08","symbol":"FDMT","fiscalQuarterEnding":"2025/03","expectedEps":-0.84,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-0.86},{"market":"US","date":"2025-02-28","symbol":"FDMT","fiscalQuarterEnding":"2024/12","expectedEps":-0.8,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740718800000,"reportTimeType":"post","actualEps":-0.9},{"market":"US","date":"2024-11-13","symbol":"FDMT","fiscalQuarterEnding":"2024/09","expectedEps":-0.67,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-0.79}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FDMT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FDMT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.5455,"hold":0.1818,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1762491600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FDMT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FDMT","date":"2026-02-10","current":-2.47289,"percent":0.810345,"low":-26.701069,"twenty":-11.791579,"median":-6.019005,"eighty":-2.299159,"high":-0.72245,"avg":-7.012858,"sd":5.272804,"marketCap":463151495},"quantilePoints":[{"date":"2021-02-12","current":-22.767135,"twenty":-23.852008,"median":-22.011779,"eighty":-19.960659,"marketCap":1189833234},{"date":"2021-02-19","current":-21.839416,"twenty":-23.828689,"median":-22.011779,"eighty":-20.168508,"marketCap":1141349716},{"date":"2021-02-26","current":-21.281771,"twenty":-23.765827,"median":-21.892646,"eighty":-20.268884,"marketCap":1112206617},{"date":"2021-03-05","current":-22.772204,"twenty":-23.697895,"median":-21.839416,"eighty":-20.435164,"marketCap":1190098171},{"date":"2021-03-12","current":-25.540153,"twenty":-23.872286,"median":-21.89518,"eighty":-20.545679,"marketCap":1334753915},{"date":"2021-03-19","current":-22.143586,"twenty":-23.963537,"median":-22.011779,"eighty":-20.579138,"marketCap":1157245951},{"date":"2021-03-26","current":-17.938699,"twenty":-23.872286,"median":-21.89518,"eighty":-20.435164,"marketCap":1016998689},{"date":"2021-04-01","current":-18.852114,"twenty":-23.829702,"median":-21.821672,"eighty":-20.259759,"marketCap":1068782875},{"date":"2021-04-09","current":-17.746656,"twenty":-23.786105,"median":-21.778582,"eighty":-19.574529,"marketCap":1006111144},{"date":"2021-04-16","current":-15.632501,"twenty":-23.707021,"median":-21.585941,"eighty":-19.257301,"marketCap":886253382},{"date":"2021-04-23","current":-16.032731,"twenty":-23.576227,"median":-21.362883,"eighty":-18.708039,"marketCap":908943604},{"date":"2021-04-30","current":-18.222223,"twenty":-23.380545,"median":-21.274166,"eighty":-18.179234,"marketCap":1033072467},{"date":"2021-05-07","current":-15.444158,"twenty":-23.295377,"median":-21.109408,"eighty":-17.847419,"marketCap":875575631},{"date":"2021-05-14","current":-11.824739,"twenty":-23.230488,"median":-20.952254,"eighty":-17.465082,"marketCap":708763011},{"date":"2021-05-21","current":-11.784579,"twenty":-23.153431,"median":-20.597388,"eighty":-16.845433,"marketCap":706355891},{"date":"2021-05-28","current":-11.851512,"twenty":-23.097666,"median":-20.480623,"eighty":-16.102418,"marketCap":710367757},{"date":"2021-06-04","current":-11.762268,"twenty":-23.058124,"median":-20.280544,"eighty":-15.63721,"marketCap":705018602},{"date":"2021-06-11","current":-12.627928,"twenty":-22.906039,"median":-20.049882,"eighty":-14.311273,"marketCap":756905404},{"date":"2021-06-18","current":-11.039398,"twenty":-22.820871,"median":-19.579402,"eighty":-12.997406,"marketCap":661690448},{"date":"2021-06-25","current":-10.088956,"twenty":-22.77119,"median":-19.487737,"eighty":-12.256677,"marketCap":604721950},{"date":"2021-07-02","current":-10.686886,"twenty":-22.721509,"median":-19.107196,"eighty":-12.072835,"marketCap":640561287},{"date":"2021-07-09","current":-10.94123,"twenty":-22.539007,"median":-18.897375,"eighty":-11.97199,"marketCap":655806378},{"date":"2021-07-16","current":-10.847524,"twenty":-22.4072,"median":-18.473266,"eighty":-11.847049,"marketCap":650189765},{"date":"2021-07-23","current":-10.963541,"twenty":-22.331158,"median":-18.186398,"eighty":-11.784579,"marketCap":657143667},{"date":"2021-07-30","current":-11.097406,"twenty":-22.143586,"median":-17.938699,"eighty":-11.405295,"marketCap":665167399},{"date":"2021-08-06","current":-12.083544,"twenty":-22.021918,"median":-17.772553,"eighty":-11.43653,"marketCap":724275559},{"date":"2021-08-13","current":-13.917953,"twenty":-22.011779,"median":-17.657192,"eighty":-11.47669,"marketCap":728952767},{"date":"2021-08-20","current":-15.113423,"twenty":-22.00164,"median":-17.002223,"eighty":-11.507925,"marketCap":791565519},{"date":"2021-08-27","current":-16.375881,"twenty":-21.945875,"median":-16.828482,"eighty":-11.552547,"marketCap":857686743},{"date":"2021-09-03","current":-16.581996,"twenty":-21.844485,"median":-16.602607,"eighty":-11.588244,"marketCap":868482045},{"date":"2021-09-10","current":-17.313706,"twenty":-21.84043,"median":-16.849671,"eighty":-11.727463,"marketCap":906805368},{"date":"2021-09-17","current":-17.932053,"twenty":-21.811026,"median":-16.921702,"eighty":-11.780117,"marketCap":939191274},{"date":"2021-09-24","current":-18.127863,"twenty":-21.787707,"median":-17.182308,"eighty":-11.788149,"marketCap":949446810},{"date":"2021-10-01","current":-13.387205,"twenty":-21.779596,"median":-16.921702,"eighty":-11.80332,"marketCap":701154864},{"date":"2021-10-08","current":-11.865436,"twenty":-21.713692,"median":-16.849671,"eighty":-11.821169,"marketCap":621452192},{"date":"2021-10-15","current":-14.143268,"twenty":-21.648803,"median":-16.602608,"eighty":-11.842587,"marketCap":740753660},{"date":"2021-10-22","current":-16.767952,"twenty":-21.555524,"median":-16.56626,"eighty":-11.850619,"marketCap":878221488},{"date":"2021-10-29","current":-14.619402,"twenty":-21.486579,"median":-16.550523,"eighty":-11.862651,"marketCap":765691199},{"date":"2021-11-05","current":-15.156255,"twenty":-21.385189,"median":-16.383232,"eighty":-11.882854,"marketCap":793808837},{"date":"2021-11-12","current":-12.021796,"twenty":-21.306105,"median":-16.224378,"eighty":-11.894777,"marketCap":802827573},{"date":"2021-11-19","current":-11.097783,"twenty":-21.283799,"median":-16.057448,"eighty":-11.842587,"marketCap":741121050},{"date":"2021-11-26","current":-10.611714,"twenty":-21.272646,"median":-15.998098,"eighty":-11.787256,"marketCap":708660848},{"date":"2021-12-03","current":-10.963031,"twenty":-21.178353,"median":-15.811427,"eighty":-11.573965,"marketCap":732122182},{"date":"2021-12-10","current":-10.553963,"twenty":-21.113464,"median":-15.65526,"eighty":-11.491899,"marketCap":704804191},{"date":"2021-12-17","current":-9.495198,"twenty":-21.051615,"median":-15.632501,"eighty":-11.353671,"marketCap":634098800},{"date":"2021-12-23","current":-10.938968,"twenty":-21.007004,"median":-15.520501,"eighty":-11.228593,"marketCap":730515242},{"date":"2021-12-31","current":-10.558775,"twenty":-20.961379,"median":-15.410567,"eighty":-11.105331,"marketCap":705125579},{"date":"2022-01-07","current":-9.028379,"twenty":-20.817404,"median":-15.252551,"eighty":-11.061911,"marketCap":602924150},{"date":"2022-01-14","current":-8.176554,"twenty":-20.649097,"median":-15.104183,"eighty":-10.983175,"marketCap":546038449},{"date":"2022-01-21","current":-6.872348,"twenty":-20.588263,"median":-15.034071,"eighty":-10.93942,"marketCap":458942263},{"date":"2022-01-28","current":-7.050413,"twenty":-20.54872,"median":-14.782253,"eighty":-10.85715,"marketCap":470833625},{"date":"2022-02-04","current":-7.863737,"twenty":-20.514182,"median":-14.503134,"eighty":-10.815224,"marketCap":525148220},{"date":"2022-02-11","current":-7.204415,"twenty":-20.396369,"median":-14.37656,"eighty":-10.734185,"marketCap":481118045},{"date":"2022-02-18","current":-6.723158,"twenty":-20.282065,"median":-14.166564,"eighty":-10.669038,"marketCap":448979231},{"date":"2022-02-25","current":-6.87716,"twenty":-20.278009,"median":-14.101501,"eighty":-10.597643,"marketCap":459263652},{"date":"2022-03-04","current":-6.33334,"twenty":-20.247592,"median":-13.897341,"eighty":-10.517324,"marketCap":422946792},{"date":"2022-03-11","current":-7.271791,"twenty":-20.049882,"median":-13.563456,"eighty":-10.401308,"marketCap":485617479},{"date":"2022-03-18","current":-7.801174,"twenty":-19.912605,"median":-13.418122,"eighty":-10.267443,"marketCap":520970174},{"date":"2022-03-25","current":-7.281416,"twenty":-19.603765,"median":-13.180183,"eighty":-10.142502,"marketCap":486260255},{"date":"2022-04-01","current":-6.947717,"twenty":-19.555039,"median":-12.98528,"eighty":-9.990892,"marketCap":495490313},{"date":"2022-04-08","current":-6.301312,"twenty":-19.555039,"median":-12.706917,"eighty":-9.533698,"marketCap":449390694},{"date":"2022-04-14","current":-5.97585,"twenty":-19.501197,"median":-12.59,"eighty":-9.336383,"marketCap":426179697},{"date":"2022-04-22","current":-5.492177,"twenty":-19.483225,"median":-12.253107,"eighty":-8.715562,"marketCap":391685576},{"date":"2022-04-29","current":-5.383689,"twenty":-19.182369,"median":-12.161632,"eighty":-8.082227,"marketCap":383948577},{"date":"2022-05-06","current":-4.759887,"twenty":-19.107051,"median":-12.132628,"eighty":-7.857962,"marketCap":339460832},{"date":"2022-05-13","current":-3.581842,"twenty":-18.9755,"median":-12.056771,"eighty":-7.629846,"marketCap":291021053},{"date":"2022-05-20","current":-3.104793,"twenty":-18.870218,"median":-12.021796,"eighty":-7.584608,"marketCap":252261313},{"date":"2022-05-27","current":-3.037211,"twenty":-18.660014,"median":-11.946361,"eighty":-7.383287,"marketCap":246770349},{"date":"2022-06-03","current":-3.057088,"twenty":-18.587402,"median":-11.907556,"eighty":-7.277566,"marketCap":248385338},{"date":"2022-06-10","current":-2.534322,"twenty":-18.512364,"median":-11.865436,"eighty":-7.218853,"marketCap":205911123},{"date":"2022-06-17","current":-2.580039,"twenty":-18.400265,"median":-11.835894,"eighty":-7.155327,"marketCap":209625598},{"date":"2022-06-24","current":-2.802662,"twenty":-18.299848,"median":-11.797966,"eighty":-7.027312,"marketCap":227713477},{"date":"2022-07-01","current":-2.766883,"twenty":-18.193563,"median":-11.762268,"eighty":-6.954949,"marketCap":224806496},{"date":"2022-07-08","current":-3.379096,"twenty":-18.146032,"median":-11.588244,"eighty":-6.87331,"marketCap":274548164},{"date":"2022-07-15","current":-4.00721,"twenty":-18.121679,"median":-11.526639,"eighty":-6.732783,"marketCap":325581822},{"date":"2022-07-22","current":-4.046964,"twenty":-18.089982,"median":-11.47669,"eighty":-6.612309,"marketCap":328811801},{"date":"2022-07-29","current":-3.736883,"twenty":-18.057758,"median":-11.39351,"eighty":-6.539318,"marketCap":303617969},{"date":"2022-08-05","current":-4.563767,"twenty":-18.029958,"median":-11.237348,"eighty":-6.424028,"marketCap":370801520},{"date":"2022-08-12","current":-3.036266,"twenty":-17.978728,"median":-11.215234,"eighty":-6.139485,"marketCap":308927886},{"date":"2022-08-19","current":-2.813479,"twenty":-17.93737,"median":-11.105331,"eighty":-5.804078,"marketCap":286260221},{"date":"2022-08-26","current":-2.625701,"twenty":-17.929817,"median":-11.097594,"eighty":-5.569926,"marketCap":267154618},{"date":"2022-09-02","current":-2.612971,"twenty":-17.896388,"median":-11.057246,"eighty":-5.432508,"marketCap":265859323},{"date":"2022-09-09","current":-2.883498,"twenty":-17.79845,"median":-11.039398,"eighty":-5.302324,"marketCap":293384344},{"date":"2022-09-16","current":-2.816662,"twenty":-17.746656,"median":-10.963286,"eighty":-4.563767,"marketCap":286584045},{"date":"2022-09-23","current":-2.565231,"twenty":-17.741947,"median":-10.938968,"eighty":-4.297415,"marketCap":261001966},{"date":"2022-09-30","current":-2.558865,"twenty":-17.657192,"median":-10.900467,"eighty":-4.203888,"marketCap":260354319},{"date":"2022-10-07","current":-2.26606,"twenty":-17.586809,"median":-10.842717,"eighty":-4.046964,"marketCap":230562531},{"date":"2022-10-14","current":-2.237416,"twenty":-17.576504,"median":-10.817296,"eighty":-3.820366,"marketCap":227648117},{"date":"2022-10-21","current":-2.180128,"twenty":-17.406458,"median":-10.749357,"eighty":-3.645448,"marketCap":221819289},{"date":"2022-10-28","current":-2.82621,"twenty":-17.337009,"median":-10.727046,"eighty":-3.486432,"marketCap":287555516},{"date":"2022-11-04","current":-2.641615,"twenty":-17.334318,"median":-10.669038,"eighty":-3.283686,"marketCap":268773737},{"date":"2022-11-11","current":-3.852057,"twenty":-17.313706,"median":-10.635776,"eighty":-3.168399,"marketCap":405228648},{"date":"2022-11-18","current":-6.771121,"twenty":-17.298248,"median":-10.558775,"eighty":-3.22008,"marketCap":712308392},{"date":"2022-11-25","current":-7.045168,"twenty":-17.211679,"median":-10.525087,"eighty":-3.239162,"marketCap":741137608},{"date":"2022-12-02","current":-6.980505,"twenty":-17.17767,"median":-10.488744,"eighty":-3.275735,"marketCap":734335209},{"date":"2022-12-09","current":-7.205286,"twenty":-17.101112,"median":-10.401308,"eighty":-3.304717,"marketCap":757981645},{"date":"2022-12-16","current":-7.177573,"twenty":-17.058694,"median":-10.316986,"eighty":-3.35255,"marketCap":755066331},{"date":"2022-12-23","current":-6.647954,"twenty":-16.973992,"median":-10.265209,"eighty":-3.375916,"marketCap":699351441},{"date":"2022-12-30","current":-6.838863,"twenty":-16.934749,"median":-10.17377,"eighty":-3.443498,"marketCap":719434715},{"date":"2023-01-06","current":-7.140623,"twenty":-16.91155,"median":-10.101581,"eighty":-3.519825,"marketCap":751179245},{"date":"2023-01-13","current":-6.783438,"twenty":-16.886137,"median":-9.998111,"eighty":-3.574686,"marketCap":713604087},{"date":"2023-01-20","current":-6.253818,"twenty":-16.862384,"median":-9.808885,"eighty":-3.581842,"marketCap":657889197},{"date":"2023-01-27","current":-6.546341,"twenty":-16.816376,"median":-9.533698,"eighty":-3.594563,"marketCap":688661956},{"date":"2023-02-03","current":-7.057485,"twenty":-16.739005,"median":-9.454291,"eighty":-3.65976,"marketCap":742433303},{"date":"2023-02-10","current":-6.232264,"twenty":-16.619097,"median":-8.840688,"eighty":-3.720981,"marketCap":655621730},{"date":"2023-02-17","current":-6.469361,"twenty":-16.598486,"median":-8.686687,"eighty":-3.738473,"marketCap":680563861},{"date":"2023-02-24","current":-5.825812,"twenty":-16.581996,"median":-8.284837,"eighty":-3.744833,"marketCap":612863791},{"date":"2023-03-03","current":-5.830431,"twenty":-16.550523,"median":-7.993676,"eighty":-3.820366,"marketCap":613349677},{"date":"2023-03-10","current":-4.757336,"twenty":-16.418835,"median":-7.878175,"eighty":-3.852057,"marketCap":500462240},{"date":"2023-03-17","current":-5.317794,"twenty":-16.390583,"median":-7.834862,"eighty":-3.907825,"marketCap":571630940},{"date":"2023-03-24","current":-5.336344,"twenty":-16.375881,"median":-7.714548,"eighty":-3.967456,"marketCap":573625001},{"date":"2023-03-31","current":-5.314702,"twenty":-16.348624,"median":-7.618296,"eighty":-4.00721,"marketCap":571298596},{"date":"2023-04-06","current":-4.980794,"twenty":-16.249227,"median":-7.603858,"eighty":-4.039013,"marketCap":535405491},{"date":"2023-04-14","current":-5.209798,"twenty":-16.210434,"median":-7.55275,"eighty":-4.050145,"marketCap":560021983},{"date":"2023-04-21","current":-6.143542,"twenty":-16.107122,"median":-7.497982,"eighty":-4.05094,"marketCap":660393875},{"date":"2023-04-28","current":-5.101582,"twenty":-16.042618,"median":-7.416545,"eighty":-4.063661,"marketCap":548389479},{"date":"2023-05-05","current":-6.093647,"twenty":-16.026933,"median":-7.353605,"eighty":-4.136421,"marketCap":655030474},{"date":"2023-05-12","current":-6.440815,"twenty":-15.981666,"median":-7.276604,"eighty":-4.193874,"marketCap":707446269},{"date":"2023-05-19","current":-5.519167,"twenty":-15.896164,"median":-7.236078,"eighty":-4.227824,"marketCap":606214214},{"date":"2023-05-26","current":-5.453425,"twenty":-15.824647,"median":-7.218853,"eighty":-4.236989,"marketCap":598993284},{"date":"2023-06-02","current":-5.660041,"twenty":-15.769816,"median":-7.207257,"eighty":-4.24971,"marketCap":621687634},{"date":"2023-06-09","current":-6.110841,"twenty":-15.707663,"median":-7.200232,"eighty":-4.273563,"marketCap":671202578},{"date":"2023-06-16","current":-8.003579,"twenty":-15.655417,"median":-7.209228,"eighty":-4.327628,"marketCap":879097128},{"date":"2023-06-23","current":-6.902134,"twenty":-15.651384,"median":-7.218853,"eighty":-4.392825,"marketCap":758116618},{"date":"2023-06-30","current":-6.757308,"twenty":-15.639017,"median":-7.205286,"eighty":-4.472333,"marketCap":742209146},{"date":"2023-07-07","current":-6.894512,"twenty":-15.635107,"median":-7.200232,"eighty":-4.503831,"marketCap":757279383},{"date":"2023-07-14","current":-7.328992,"twenty":-15.575998,"median":-7.204415,"eighty":-4.548192,"marketCap":805001798},{"date":"2023-07-21","current":-6.871644,"twenty":-15.527632,"median":-7.1882,"eighty":-4.600073,"marketCap":754767677},{"date":"2023-07-28","current":-6.783986,"twenty":-15.49558,"median":-7.169875,"eighty":-4.649475,"marketCap":745139470},{"date":"2023-08-04","current":-6.867833,"twenty":-15.45539,"median":-7.145243,"eighty":-4.701285,"marketCap":754349059},{"date":"2023-08-11","current":-6.287103,"twenty":-15.430722,"median":-7.117789,"eighty":-4.757846,"marketCap":700182117},{"date":"2023-08-18","current":-5.96614,"twenty":-15.361036,"median":-7.100594,"eighty":-4.779335,"marketCap":664437084},{"date":"2023-08-25","current":-6.321088,"twenty":-15.288328,"median":-7.074476,"eighty":-4.869807,"marketCap":703966885},{"date":"2023-09-01","current":-6.14739,"twenty":-15.233292,"median":-7.048687,"eighty":-4.930112,"marketCap":684622514},{"date":"2023-09-08","current":-5.962364,"twenty":-15.175514,"median":-7.045168,"eighty":-4.958848,"marketCap":664016554},{"date":"2023-09-15","current":-5.954812,"twenty":-15.130556,"median":-7.011912,"eighty":-4.970775,"marketCap":663175494},{"date":"2023-09-22","current":-5.456375,"twenty":-15.106031,"median":-6.997415,"eighty":-4.975722,"marketCap":607665561},{"date":"2023-09-29","current":-4.772912,"twenty":-15.082857,"median":-6.980505,"eighty":-4.96921,"marketCap":531549667},{"date":"2023-10-05","current":-4.553902,"twenty":-15.046597,"median":-6.969605,"eighty":-4.904546,"marketCap":507158938},{"date":"2023-10-13","current":-3.855335,"twenty":-15.033983,"median":-6.959302,"eighty":-4.767702,"marketCap":429360925},{"date":"2023-10-19","current":-3.930856,"twenty":-15.009397,"median":-6.95168,"eighty":-4.701285,"marketCap":437771521},{"date":"2023-10-27","current":-4.0026,"twenty":-14.960928,"median":-6.947717,"eighty":-4.634161,"marketCap":445761588},{"date":"2023-11-03","current":-4.066793,"twenty":-14.834336,"median":-6.92215,"eighty":-4.533211,"marketCap":452910594},{"date":"2023-11-10","current":-4.602757,"twenty":-14.73443,"median":-6.909757,"eighty":-4.4672,"marketCap":441556290},{"date":"2023-11-17","current":-4.915642,"twenty":-14.65266,"median":-6.89594,"eighty":-4.482759,"marketCap":471572285},{"date":"2023-11-24","current":-5.486088,"twenty":-14.526387,"median":-6.874754,"eighty":-4.503757,"marketCap":526296902},{"date":"2023-12-01","current":-5.668809,"twenty":-14.382743,"median":-6.871644,"eighty":-4.530417,"marketCap":543825881},{"date":"2023-12-08","current":-6.497739,"twenty":-14.37656,"median":-6.862116,"eighty":-4.54484,"marketCap":623347590},{"date":"2023-12-15","current":-7.402431,"twenty":-14.318848,"median":-6.860211,"eighty":-4.557848,"marketCap":710137412},{"date":"2023-12-22","current":-9.11377,"twenty":-14.215311,"median":-6.869739,"eighty":-4.579363,"marketCap":874311263},{"date":"2023-12-29","current":-9.36334,"twenty":-14.18986,"median":-6.871644,"eighty":-4.602757,"marketCap":898253283},{"date":"2024-01-05","current":-8.935505,"twenty":-14.161905,"median":-6.874754,"eighty":-4.615669,"marketCap":857209820},{"date":"2024-01-12","current":-8.378429,"twenty":-14.135585,"median":-6.897368,"eighty":-4.634161,"marketCap":803767811},{"date":"2024-01-19","current":-7.598522,"twenty":-14.107293,"median":-6.909757,"eighty":-4.659359,"marketCap":728948999},{"date":"2024-01-26","current":-8.503214,"twenty":-14.010705,"median":-6.92215,"eighty":-4.689488,"marketCap":815738821},{"date":"2024-02-02","current":-8.320493,"twenty":-13.909708,"median":-6.947717,"eighty":-4.718621,"marketCap":798209842},{"date":"2024-02-09","current":-13.835029,"twenty":-14.107293,"median":-6.959302,"eighty":-4.758356,"marketCap":1327235831},{"date":"2024-02-16","current":-14.241336,"twenty":-14.215311,"median":-6.973412,"eighty":-4.765097,"marketCap":1366214133},{"date":"2024-02-23","current":-13.464723,"twenty":-14.180542,"median":-6.989792,"eighty":-4.779709,"marketCap":1291711303},{"date":"2024-03-01","current":-13.710208,"twenty":-14.239525,"median":-7.006936,"eighty":-4.816942,"marketCap":1382496208},{"date":"2024-03-08","current":-14.567595,"twenty":-14.29071,"median":-7.045168,"eighty":-4.868828,"marketCap":1468952527},{"date":"2024-03-15","current":-14.498484,"twenty":-14.340085,"median":-7.053949,"eighty":-4.915794,"marketCap":1461983589},{"date":"2024-03-22","current":-16.685351,"twenty":-14.389691,"median":-7.081262,"eighty":-4.917227,"marketCap":1682500692},{"date":"2024-03-28","current":-17.707205,"twenty":-14.513293,"median":-7.103673,"eighty":-4.920533,"marketCap":1785541415},{"date":"2024-04-05","current":-13.64447,"twenty":-14.524209,"median":-7.124184,"eighty":-4.924555,"marketCap":1375867430},{"date":"2024-04-12","current":-14.052996,"twenty":-14.513293,"median":-7.140623,"eighty":-4.929012,"marketCap":1417061974},{"date":"2024-04-19","current":-12.571597,"twenty":-14.498484,"median":-7.169875,"eighty":-4.942382,"marketCap":1267682156},{"date":"2024-04-26","current":-11.937437,"twenty":-14.498484,"median":-7.196048,"eighty":-4.968427,"marketCap":1203735316},{"date":"2024-05-03","current":-13.383323,"twenty":-14.390397,"median":-7.207257,"eighty":-4.972341,"marketCap":1349534111},{"date":"2024-05-10","current":-12.679095,"twenty":-14.386865,"median":-7.218853,"eighty":-4.980594,"marketCap":1325675483},{"date":"2024-05-17","current":-12.679095,"twenty":-14.37656,"median":-7.232027,"eighty":-4.980794,"marketCap":1325675483},{"date":"2024-05-24","current":-12.436788,"twenty":-14.37656,"median":-7.252541,"eighty":-4.983886,"marketCap":1300340811},{"date":"2024-05-31","current":-12.184591,"twenty":-14.350671,"median":-7.281416,"eighty":-4.996418,"marketCap":1273972071},{"date":"2024-06-07","current":-11.160966,"twenty":-14.327741,"median":-7.341299,"eighty":-5.081176,"marketCap":1166946008},{"date":"2024-06-14","current":-12.070855,"twenty":-14.311283,"median":-7.372156,"eighty":-5.133119,"marketCap":1262080286},{"date":"2024-06-21","current":-11.180747,"twenty":-14.278367,"median":-7.422407,"eighty":-5.160242,"marketCap":1169014145},{"date":"2024-06-28","current":-10.349979,"twenty":-14.25368,"median":-7.458151,"eighty":-5.166341,"marketCap":1082152413},{"date":"2024-07-05","current":-10.310419,"twenty":-14.235902,"median":-7.508768,"eighty":-5.174956,"marketCap":1078016140},{"date":"2024-07-12","current":-12.753271,"twenty":-14.208364,"median":-7.530987,"eighty":-5.197216,"marketCap":1333430995},{"date":"2024-07-15","current":-13.460412,"twenty":-14.200393,"median":-7.538547,"eighty":-5.2034,"marketCap":1407366874},{"date":"2024-08-02","current":-8.500532,"twenty":-14.192421,"median":-7.546107,"eighty":-5.209583,"marketCap":888781652},{"date":"2024-08-09","current":-6.965977,"twenty":-14.18986,"median":-7.538547,"eighty":-5.209798,"marketCap":765512060},{"date":"2024-08-16","current":-6.942331,"twenty":-14.187484,"median":-7.519553,"eighty":-5.252469,"marketCap":762913581},{"date":"2024-08-23","current":-6.84302,"twenty":-14.143268,"median":-7.477886,"eighty":-5.280693,"marketCap":751999967},{"date":"2024-08-30","current":-7.21189,"twenty":-14.130463,"median":-7.442383,"eighty":-5.283785,"marketCap":792536247},{"date":"2024-09-06","current":-7.334847,"twenty":-14.120792,"median":-7.390707,"eighty":-5.286321,"marketCap":806048340},{"date":"2024-09-13","current":-7.524011,"twenty":-14.098628,"median":-7.388787,"eighty":-5.29925,"marketCap":826836176},{"date":"2024-09-20","current":-6.384296,"twenty":-14.088372,"median":-7.402431,"eighty":-5.312226,"marketCap":701589465},{"date":"2024-09-27","current":-5.183103,"twenty":-14.084463,"median":-7.370236,"eighty":-5.312226,"marketCap":569586706},{"date":"2024-10-04","current":-4.889898,"twenty":-14.074795,"median":-7.344305,"eighty":-5.275048,"marketCap":537365560},{"date":"2024-10-11","current":-4.128512,"twenty":-14.056905,"median":-7.331919,"eighty":-5.182216,"marketCap":453694520},{"date":"2024-10-18","current":-3.996097,"twenty":-14.026745,"median":-7.281416,"eighty":-5.119732,"marketCap":439143035},{"date":"2024-10-25","current":-3.882598,"twenty":-13.99138,"median":-7.262166,"eighty":-4.983268,"marketCap":426670333},{"date":"2024-10-31","current":-3.910973,"twenty":-13.963992,"median":-7.245069,"eighty":-4.970775,"marketCap":429788509},{"date":"2024-11-08","current":-3.915702,"twenty":-13.930985,"median":-7.235536,"eighty":-4.923934,"marketCap":430308205},{"date":"2024-11-15","current":-2.583958,"twenty":-13.905586,"median":-7.218853,"eighty":-4.905344,"marketCap":370746226},{"date":"2024-11-22","current":-2.574292,"twenty":-13.859954,"median":-7.21189,"eighty":-4.793302,"marketCap":369359394},{"date":"2024-11-29","current":-2.525963,"twenty":-13.825942,"median":-7.209228,"eighty":-4.731887,"marketCap":362425238},{"date":"2024-12-06","current":-2.19733,"twenty":-13.805848,"median":-7.200232,"eighty":-4.630867,"marketCap":315272975},{"date":"2024-12-13","current":-2.216662,"twenty":-13.790769,"median":-7.180352,"eighty":-4.54484,"marketCap":318046637},{"date":"2024-12-20","current":-1.862254,"twenty":-13.753698,"median":-7.156021,"eighty":-4.464634,"marketCap":267196158},{"date":"2024-12-27","current":-1.871919,"twenty":-13.709457,"median":-7.137544,"eighty":-4.379364,"marketCap":268582989},{"date":"2025-01-03","current":-1.878363,"twenty":-13.706451,"median":-7.128672,"eighty":-4.336592,"marketCap":269507543},{"date":"2025-01-10","current":-1.881585,"twenty":-13.671173,"median":-7.11381,"eighty":-4.257368,"marketCap":269969820},{"date":"2025-01-17","current":-1.507846,"twenty":-13.661924,"median":-7.098392,"eighty":-4.218123,"marketCap":216345678},{"date":"2025-01-24","current":-1.569061,"twenty":-13.651409,"median":-7.093662,"eighty":-4.143694,"marketCap":225128942},{"date":"2025-01-31","current":-1.80426,"twenty":-13.629198,"median":-7.074611,"eighty":-4.066822,"marketCap":258875170},{"date":"2025-02-07","current":-2.100674,"twenty":-13.605447,"median":-7.057485,"eighty":-4.052084,"marketCap":301404662},{"date":"2025-02-14","current":-1.520733,"twenty":-13.584225,"median":-7.046064,"eighty":-4.033481,"marketCap":218194786},{"date":"2025-02-21","current":-1.504624,"twenty":-13.574078,"median":-7.018003,"eighty":-4.009897,"marketCap":215883401},{"date":"2025-02-28","current":-1.443408,"twenty":-13.538654,"median":-6.99908,"eighty":-3.967562,"marketCap":207100136},{"date":"2025-03-07","current":-1.19161,"twenty":-13.480088,"median":-6.985148,"eighty":-3.938036,"marketCap":191691964},{"date":"2025-03-14","current":-1.231906,"twenty":-13.464946,"median":-6.970706,"eighty":-3.906876,"marketCap":198174301},{"date":"2025-03-21","current":-1.079357,"twenty":-13.462999,"median":-6.964456,"eighty":-3.859619,"marketCap":173634026},{"date":"2025-03-28","current":-1.02467,"twenty":-13.460214,"median":-6.955491,"eighty":-3.832942,"marketCap":164836568},{"date":"2025-04-04","current":-0.830385,"twenty":-13.4432,"median":-6.945024,"eighty":-3.792179,"marketCap":133582444},{"date":"2025-04-11","current":-0.745476,"twenty":-13.406232,"median":-6.92864,"eighty":-3.718927,"marketCap":119923234},{"date":"2025-04-17","current":-0.837581,"twenty":-13.388158,"median":-6.913568,"eighty":-3.581842,"marketCap":134740004},{"date":"2025-04-25","current":-0.935443,"twenty":-13.386429,"median":-6.899751,"eighty":-3.366374,"marketCap":150482822},{"date":"2025-05-02","current":-0.99013,"twenty":-13.383323,"median":-6.87716,"eighty":-3.22485,"marketCap":159280280},{"date":"2025-05-09","current":-0.932565,"twenty":-13.382238,"median":-6.871644,"eighty":-3.101612,"marketCap":150019798},{"date":"2025-05-16","current":-0.840171,"twenty":-13.37594,"median":-6.864022,"eighty":-3.042976,"marketCap":148238854},{"date":"2025-05-23","current":-0.945192,"twenty":-13.366074,"median":-6.840941,"eighty":-3.020543,"marketCap":166768711},{"date":"2025-05-30","current":-0.974073,"twenty":-13.357956,"median":-6.834278,"eighty":-3.009383,"marketCap":171864421},{"date":"2025-06-06","current":-1.026583,"twenty":-13.34828,"median":-6.824103,"eighty":-2.973604,"marketCap":181129350},{"date":"2025-06-13","current":-1.18149,"twenty":-13.31737,"median":-6.819253,"eighty":-2.949752,"marketCap":208460889},{"date":"2025-06-20","current":-1.073843,"twenty":-13.303159,"median":-6.799765,"eighty":-2.9259,"marketCap":189467785},{"date":"2025-06-27","current":-1.068592,"twenty":-13.108528,"median":-6.783986,"eighty":-2.882437,"marketCap":188541292},{"date":"2025-07-03","current":-1.113226,"twenty":-13.060759,"median":-6.771284,"eighty":-2.852308,"marketCap":196416482},{"date":"2025-07-11","current":-1.142107,"twenty":-13.015472,"median":-6.762331,"eighty":-2.839577,"marketCap":201512192},{"date":"2025-07-18","current":-1.144732,"twenty":-12.983053,"median":-6.743364,"eighty":-2.820188,"marketCap":201975439},{"date":"2025-07-25","current":-1.210371,"twenty":-12.948435,"median":-6.719427,"eighty":-2.802662,"marketCap":213556599},{"date":"2025-08-01","current":-1.18149,"twenty":-12.89918,"median":-6.694141,"eighty":-2.778925,"marketCap":208460889},{"date":"2025-08-08","current":-1.517558,"twenty":-12.866697,"median":-6.672626,"eighty":-2.74537,"marketCap":267756430},{"date":"2025-08-15","current":-1.690531,"twenty":-12.844092,"median":-6.647954,"eighty":-2.666998,"marketCap":331587515},{"date":"2025-08-22","current":-1.631005,"twenty":-12.820188,"median":-6.626587,"eighty":-2.645434,"marketCap":319911898},{"date":"2025-08-29","current":-1.471476,"twenty":-12.794479,"median":-6.608693,"eighty":-2.625701,"marketCap":288621246},{"date":"2025-09-05","current":-1.573861,"twenty":-12.771771,"median":-6.588771,"eighty":-2.614244,"marketCap":308703306},{"date":"2025-09-12","current":-1.683388,"twenty":-12.745359,"median":-6.555148,"eighty":-2.580481,"marketCap":330186441},{"date":"2025-09-19","current":-1.690531,"twenty":-12.723601,"median":-6.535468,"eighty":-2.561411,"marketCap":331587515},{"date":"2025-09-26","current":-2.004827,"twenty":-12.696898,"median":-6.525987,"eighty":-2.529952,"marketCap":393234772},{"date":"2025-10-03","current":-2.064353,"twenty":-12.679095,"median":-6.497739,"eighty":-2.504888,"marketCap":404910388},{"date":"2025-10-10","current":-2.276264,"twenty":-12.667227,"median":-6.475519,"eighty":-2.484713,"marketCap":446475584},{"date":"2025-10-17","current":-2.402459,"twenty":-12.647447,"median":-6.459523,"eighty":-2.447512,"marketCap":471227892},{"date":"2025-10-24","current":-2.38103,"twenty":-12.63858,"median":-6.442538,"eighty":-2.433282,"marketCap":467024670},{"date":"2025-10-31","current":-2.695326,"twenty":-12.629009,"median":-6.426433,"eighty":-2.447512,"marketCap":528671926},{"date":"2025-11-07","current":-2.600084,"twenty":-12.611484,"median":-6.418283,"eighty":-2.452426,"marketCap":509990939},{"date":"2025-11-14","current":-2.807902,"twenty":-12.580729,"median":-6.413936,"eighty":-2.459676,"marketCap":587348571},{"date":"2025-11-21","current":-2.824291,"twenty":-12.563787,"median":-6.389179,"eighty":-2.473572,"marketCap":590776675},{"date":"2025-11-28","current":-3.184839,"twenty":-12.547806,"median":-6.379101,"eighty":-2.484396,"marketCap":666194974},{"date":"2025-12-05","current":-3.056462,"twenty":-12.511953,"median":-6.36159,"eighty":-2.487975,"marketCap":639341489},{"date":"2025-12-12","current":-2.982713,"twenty":-12.436788,"median":-6.355072,"eighty":-2.492596,"marketCap":623915019},{"date":"2025-12-19","current":-2.373606,"twenty":-12.283658,"median":-6.321088,"eighty":-2.48503,"marketCap":496503801},{"date":"2025-12-26","current":-2.212452,"twenty":-12.224761,"median":-6.306165,"eighty":-2.448559,"marketCap":462794107},{"date":"2026-01-02","current":-2.048567,"twenty":-12.142627,"median":-6.290769,"eighty":-2.402733,"marketCap":428513062},{"date":"2026-01-09","current":-1.993938,"twenty":-12.062405,"median":-6.253119,"eighty":-2.373775,"marketCap":417086047},{"date":"2026-01-16","current":-2.078612,"twenty":-11.982699,"median":-6.229185,"eighty":-2.364197,"marketCap":434797920},{"date":"2026-01-23","current":-2.209721,"twenty":-11.909011,"median":-6.14739,"eighty":-2.341171,"marketCap":462222756},{"date":"2026-01-30","current":-2.450086,"twenty":-11.858138,"median":-6.106939,"eighty":-2.3216,"marketCap":512501622},{"date":"2026-02-06","current":-2.045904,"twenty":-11.81403,"median":-6.056765,"eighty":-2.301646,"marketCap":427956062},{"date":"2026-02-10","current":-2.214161,"twenty":-11.791579,"median":-6.019005,"eighty":-2.299159,"marketCap":463151495}],"updateTime":1770843573109},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FDMT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610765843","title":"4D Molecular Therapeutics Completes Enrollment for Phase 3 Wet AMD Trial of 4D-150","url":"https://stock-news.laohu8.com/highlight/detail?id=2610765843","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610765843?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:00","pubTimestamp":1770642044,"startTime":"0","endTime":"0","summary":"4D Molecular Therapeutics Inc. announced the completion of enrollment for 4FRONT-1, the first Phase 3 clinical trial evaluating 4D-150 in patients with wet age-related macular degeneration . The trial enrolled over 500 patients within approximately 11 months, exceeding initial projections. Topline data from 4FRONT-1 are expected in the first half of 2027. Additionally, the company reported ongoing global site activation for 4FRONT-2, with enrollment completion anticipated in the second half of 2026 and topline data expected in the second half of 2027. No results from these trials have been presented yet.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4D Molecular Therapeutics Inc. published the original content used to generate this ne","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL62ysys:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014005.SGD","BK4112","SG9999014013.SGD","FDMT","LU0314104364.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","SG9999014039.USD","BK4588","BK4139","IE00BKPKM429.USD","LU2210150020.SGD","BK4585","LU2095319765.USD","SG9999014021.USD","NDAQ"],"gpt_icon":0},{"id":"2610658192","title":"4Dmt Completes Enrollment for 4Front-1 Phase 3 Clinical Trial of 4D-150 in Wet Amd","url":"https://stock-news.laohu8.com/highlight/detail?id=2610658192","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610658192?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:00","pubTimestamp":1770642005,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nTUA7KV0NG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FDMT","BK4139"],"gpt_icon":0},{"id":"2606714149","title":"4D Molecular Therapeutics Initiated at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2606714149","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606714149?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:47","pubTimestamp":1769608020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FDMT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 28, 2026 08:47 ET (13:47 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FDMT"],"gpt_icon":0},{"id":"2606226349","title":"4D Molecular Therapeutics Issues Pre-Funded Warrants in Exchange for Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2606226349","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606226349?lang=en_us&edition=fundamental","pubTime":"2026-01-27 05:06","pubTimestamp":1769461570,"startTime":"0","endTime":"0","summary":"4D Molecular Therapeutics Inc. has announced the issuance of pre-funded warrants in exchange for common stock through unregistered sales to RA Capital Healthcare Fund, L.P. and Biotechnology Value Fund, L.P. and its affiliates. RA Capital exchanged 4,850,000 shares of common stock for a pre-funded warrant to acquire the same number of shares, while BVF exchanged 1,750,000 shares for a similar warrant. The pre-funded warrants have an exercise price of $0.0001 per share, are immediately exercisable subject to beneficial ownership limitations, and will not expire until fully exercised. Following the transaction, as of January 23, 2026, the company reported 51,007,874 shares outstanding, excluding 16,935,665 shares issuable upon exercise of all outstanding pre-funded warrants. The transaction was made without registration, relying on an exemption under Section 3 of the Securities Act of 1933.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL2xLw1m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FDMT","BK4139"],"gpt_icon":0},{"id":"2604158839","title":"4D Molecular announces employment inducement grants","url":"https://stock-news.laohu8.com/highlight/detail?id=2604158839","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604158839?lang=en_us&edition=fundamental","pubTime":"2026-01-20 02:35","pubTimestamp":1768847706,"startTime":"0","endTime":"0","summary":"4D Molecular (FDMT) Therapeutics announced that on January 13, 2026, the compensation committee of the Company’s board of directors granted four ne...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/4d-molecular-announces-employment-inducement-grants-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/4d-molecular-announces-employment-inducement-grants-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FDMT","BK4139"],"gpt_icon":0},{"id":"2603599830","title":"Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Centene (CNC) and Cencora (COR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603599830","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603599830?lang=en_us&edition=fundamental","pubTime":"2026-01-16 19:40","pubTimestamp":1768563628,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on 4D Molecular Therapeutics (FDMT – Research Report), Centene (CNC ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-4d-molecular-therapeutics-fdmt-centene-cnc-and-cencora-cor-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-4d-molecular-therapeutics-fdmt-centene-cnc-and-cencora-cor-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1084165304.USD","LU0128526141.USD","LU1989771016.USD","LU2362541513.USD","BK4585","BK4154","BK4084","LU1201861249.SGD","LU1261432733.SGD","BK4175","BK4137","LU0289739699.SGD","LU1291159041.SGD","LU1814569148.SGD","LU1699723380.USD","LU2362541273.HKD","LU0648000940.SGD","IE0034235188.USD","LU1430594728.SGD","LU0029874061.USD","LABU","SGXZ23171101.USD","LU0980610538.SGD","LU2362540622.SGD","COR","BK4529","FDMT","LU1201861165.SGD","LU0477156797.USD","BK4588","LU0130103400.USD","LU2237957811.SGD","LU0130102774.USD","SG9999004303.SGD","HCSG","LU0477156953.USD","LU2237957902.USD","LU2324357040.USD","LU0648001328.SGD","BK4581","CNC","LU1119994496.HKD","XBI","LU1585245621.USD","LU0058720904.USD","LU0130517989.USD","XLV","LU0130518102.USD","BK4139"],"gpt_icon":0},{"id":"2603610353","title":"4D Molecular Therapeutics Unveils Gene Therapy Pipeline Targeting Retinal Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2603610353","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603610353?lang=en_us&edition=fundamental","pubTime":"2026-01-14 23:31","pubTimestamp":1768404685,"startTime":"0","endTime":"0","summary":"4D Molecular Therapeutics Inc. presented an update on its pipeline, with a focus on advancing its lead product, 4D-150, a gene therapy candidate for wet age-related macular degeneration . The presentation highlighted significant enrollment progress in the 4FRONT-1 and 4FRONT-2 global clinical trials for retinal vascular diseases, with both studies exceeding initial expectations in patient recruitment. 4D-150 aims to offer a durable, in-office treatment alternative to lifelong injections for large market retinal diseases. The company also outlined ongoing development for additional retinal and pulmonary indications, including geographic atrophy and lung diseases. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDL9D9DHv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FDMT"],"gpt_icon":0},{"id":"2601620806","title":"BRIEF-4Dmt Provides Company Update And Anticipated Development Milestones For 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601620806","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601620806?lang=en_us&edition=fundamental","pubTime":"2026-01-07 21:54","pubTimestamp":1767794059,"startTime":"0","endTime":"0","summary":"BRIEF-4Dmt Provides Company Update And Anticipated Development Milestones For 2026Jan 7 (Reuters) - 4D Molecular Therapeutics Inc FDMT.O:4DMT PROVIDES COMPANY UPDATE AND ANTICIPATED DEVELOPMENT MILEST","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nTUA4THYJM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FDMT","BK4139"],"gpt_icon":0},{"id":"2601680315","title":"4D Molecular Therapeutics Reports Strong Cash Position and Advances Key Clinical Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2601680315","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601680315?lang=en_us&edition=fundamental","pubTime":"2026-01-07 21:02","pubTimestamp":1767790936,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4D Molecular Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on January 07, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDLbs7SxG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU2210150020.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","SG9999014039.USD","FDMT","BK4139","LU2095319765.USD","BK4585","NDAQ","BK4588","LU2210149790.SGD","BK4112","SG9999014013.SGD","SG9999014005.SGD","SG9999014021.USD","IE00BKPKM429.USD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2601956803","title":"Glenn Sblendorio Joins 4D Molecular Therapeutics Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2601956803","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601956803?lang=en_us&edition=fundamental","pubTime":"2026-01-07 21:00","pubTimestamp":1767790853,"startTime":"0","endTime":"0","summary":"4D Molecular Therapeutics Inc. announced that Glenn P. Sblendorio has joined its Board of Directors. Sblendorio will serve on the Compensation and Science & Technology committees.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4D Molecular Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on January 07, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDLccm1nw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","SG9999014013.SGD","LU2095319765.USD","BK4139","LU2210150020.SGD","SG9999014039.USD","BK4112","IE00B64PRP62.GBP","IE00BGHQF748.EUR","FDMT","NDAQ","BK4588","LU2210149790.SGD","SG9999014005.SGD","LU0314104364.USD","BK4585","SG9999014021.USD","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2601644803","title":"4Dmt Provides Company Update and Anticipated Development Milestones for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601644803","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601644803?lang=en_us&edition=fundamental","pubTime":"2026-01-07 21:00","pubTimestamp":1767790806,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nTUA4THYJM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","FDMT"],"gpt_icon":0},{"id":"2592819727","title":"4D Molecular Therapeutics Inc. Files Initial Beneficial Ownership Statement for Officer Christopher Paul Simms","url":"https://stock-news.laohu8.com/highlight/detail?id=2592819727","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592819727?lang=en_us&edition=fundamental","pubTime":"2025-12-20 05:12","pubTimestamp":1766178778,"startTime":"0","endTime":"0","summary":"4D Molecular Therapeutics Inc. has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing lists Christopher Paul Simms as the beneficial owner, serving in the role of officer at the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4D Molecular Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 19, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDL3DpMt4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"4D Molecular Therapeutics Inc. Files Initial Beneficial Ownership Statement for Officer Christopher Paul Simms","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FDMT","BK4139"],"gpt_icon":0},{"id":"2592972411","title":"Chief Legal Officer Scott Bizily Reports Disposal of 4D Molecular Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592972411","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592972411?lang=en_us&edition=fundamental","pubTime":"2025-12-20 05:11","pubTimestamp":1766178673,"startTime":"0","endTime":"0","summary":"Scott Bizily, Chief Legal Officer of 4D Molecular Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4D Molecular Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDL7N9JYG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Chief Legal Officer Scott Bizily Reports Disposal of 4D Molecular Therapeutics Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FDMT"],"gpt_icon":0},{"id":"2592905608","title":"4D Molecular Therapeutics Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2592905608","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592905608?lang=en_us&edition=fundamental","pubTime":"2025-12-18 20:42","pubTimestamp":1766061720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FDMT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 18, 2025 07:42 ET (12:42 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FDMT"],"gpt_icon":0},{"id":"2592999283","title":"4D Molecular Therapeutics Reports Positive Interim Phase 1 Results for 4D-710 in Cystic Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2592999283","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592999283?lang=en_us&edition=fundamental","pubTime":"2025-12-17 20:00","pubTimestamp":1765972829,"startTime":"0","endTime":"0","summary":"4D Molecular Therapeutics Inc. announced positive interim clinical data from its Phase 1 AEROW clinical trial evaluating 4D-710 for the treatment of cystic fibrosis  lung disease. The results showed that the selected Phase 2 dose of 4D-710 was well tolerated, with no severe adverse events related to the drug, and achieved physiologically relevant levels of CFTR expression. Clinically meaningful activity was observed in multiple endpoints, including lung function and quality of life measures, with follow-up through one year. The data were presented in a company webcast on December 17, 2025. Enrollment for the Phase 2 Dose-Expansion cohort is expected to be completed in the first half of 2026, with a program update anticipated in the second half of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and shou","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL9rvlDM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BKPKM429.USD","SG9999014021.USD","BK4112","IE00B64PRP62.GBP","LU2210149790.SGD","BK4139","LU0314104364.USD","SG9999014005.SGD","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4585","LU2210150020.SGD","NDAQ","SG9999014013.SGD","FDMT","BK4588"],"gpt_icon":0},{"id":"2592994014","title":"4Dmt Announces Positive Interim Clinical Data From 4D-710 Aerow Phase 1 Clinical Trial in Cystic Fibrosis Lung Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2592994014","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592994014?lang=en_us&edition=fundamental","pubTime":"2025-12-17 20:00","pubTimestamp":1765972803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUA8DLY5V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FDMT","BK4139"],"gpt_icon":0},{"id":"2591073689","title":"4D Molecular Therapeutics Grants 13,800 RSUs to New Employees Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2591073689","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591073689?lang=en_us&edition=fundamental","pubTime":"2025-12-13 05:05","pubTimestamp":1765573506,"startTime":"0","endTime":"0","summary":"4D Molecular Therapeutics Inc. has granted 13,800 Restricted Stock Units  to three new non-executive employees as part of its 2025 Employment Inducement Award Plan. The RSUs were approved by the company's board of directors and are intended for newly hired team members.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4D Molecular Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on December 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDL6FygSV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","SG9999014013.SGD","LU0314104364.USD","BK4139","LU2210150020.SGD","SG9999014039.USD","BK4112","FDMT","IE00B3QW5Z07.USD","LU2210149790.SGD","SG9999014021.USD","NDAQ","BK4588","SG9999014005.SGD","IE00B64PRP62.GBP","BK4585","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2590549789","title":"4D Molecular Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Kristian Humer, Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2590549789","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590549789?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:14","pubTimestamp":1765487655,"startTime":"0","endTime":"0","summary":"4D Molecular Therapeutics Inc. has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing lists Kristian Humer as the beneficial owner in his capacity as Chief Financial Officer of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4D Molecular Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL3l4SnV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"4D Molecular Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Kristian Humer, Chief Financial Officer","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FDMT","BK4139"],"gpt_icon":0},{"id":"2589035338","title":"4D Molecular Therapeutics to Present at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2589035338","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589035338?lang=en_us&edition=fundamental","pubTime":"2025-12-08 21:00","pubTimestamp":1765198830,"startTime":"0","endTime":"0","summary":"4D Molecular Therapeutics Inc. will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 7:30 a.m. PT. Members of the company's management team will also be available for one-on-one meetings during the event. An archived webcast of the presentation will be accessible on the 4DMT website for up to one year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4D Molecular Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on December 08, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDLbyHbgG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0314104364.USD","BK4112","BK4585","LU2210149790.SGD","FDMT","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU2095319765.USD","SG9999014021.USD","SG9999014013.SGD","NDAQ","IE00BKPKM429.USD","LU2210150020.SGD","BK4139","SG9999014005.SGD","IE00BGHQF748.EUR","SG9999014039.USD"],"gpt_icon":0},{"id":"2584684906","title":"Chief Legal Officer Scott Bizily Reports Disposal of 4D Molecular Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584684906","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584684906?lang=en_us&edition=fundamental","pubTime":"2025-11-20 10:54","pubTimestamp":1763607283,"startTime":"0","endTime":"0","summary":"Scott Bizily, Chief Legal Officer of 4D Molecular Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4D Molecular Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 19, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL6RwYTx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Chief Legal Officer Scott Bizily Reports Disposal of 4D Molecular Therapeutics Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FDMT","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":76,"code":"91000000","status":"200"}]}}